Investigations of Valanimycin Biosynthesis: Elucidation of the Role of Seryl-tRNA

Overview

Journal Proc Natl Acad Sci U S A

Specialty Science

Date 2008 May 3

PMID 18451033

Citations 48

Authors

Ram P Garg

Xuelei L Qian

Lawrence B Alemany

Sean Moran

Ronald J Parry

Affiliations

Soon will be listed here.

Abstract

The antibiotic valanimycin is a naturally occurring azoxy compound produced by Streptomyces viridifaciens MG456-hF10. Precursor incorporation experiments showed that valanimycin is derived from l-valine and l-serine via the intermediacy of isobutylamine and isobutylhydroxylamine. Enzymatic and genetic investigations led to the cloning and sequencing of the valanimycin biosynthetic gene cluster, which was found to contain 14 genes. A novel feature of the valanimycin biosynthetic gene cluster is the presence of a gene (vlmL) that encodes a class II seryl-tRNA synthetase. Previous studies suggested that the role of this enzyme is to provide seryl-tRNA for the valanimycin biosynthetic pathway. Here, we report the results of investigations to elucidate the role of seryl-tRNA in valanimycin biosynthesis. A combination of enzymatic and chemical studies has revealed that the VlmA protein encoded by the valanimycin biosynthetic gene cluster catalyzes the transfer of the seryl residue from seryl-tRNA to the hydroxyl group of isobutylhydroxylamine to produce the ester O-seryl-isobutylhydroxylamine. These findings provide an example of the involvement of an aminoacyl-tRNA in an antibiotic biosynthetic pathway.

Citing Articles

Reconstitution of the Final Steps in the Biosynthesis of Valanimycin Reveals the Origin of Its Characteristic Azoxy Moiety.

Zheng Z, Xiong J, Bu J, Ren D, Lee Y, Yeh Y Angew Chem Int Ed Engl. 2023; 63(1):e202315844.

PMID: 37963815 PMC: 10843709. DOI: 10.1002/anie.202315844.

Streptomyces lividans 66 produces a protease inhibitor via a tRNA-utilizing enzyme interacting with a C-minus NRPS.

Aguilar C, Verdel-Aranda K, Ramos-Aboites H, Licona-Cassani C, Barona-Gomez F J Ind Microbiol Biotechnol. 2023; 50(1).

PMID: 37669898 PMC: 10548850. DOI: 10.1093/jimb/kuad021.

Traceless Staudinger Ligation to Access Stable Aminoacyl- or Peptidyl-Dinucleotide.

Kitoun C, Saidjalolov S, Bouquet D, Djago F, Remaury Q, Sargueil B ACS Omega. 2023; 8(4):3850-3860.

PMID: 36743074 PMC: 9893454. DOI: 10.1021/acsomega.2c06135.

Genome mining for unknown-unknown natural products.

Yee D, Niwa K, Perlatti B, Chen M, Li Y, Tang Y Nat Chem Biol. 2023; 19(5):633-640.

PMID: 36702957 PMC: 10159913. DOI: 10.1038/s41589-022-01246-6.

Diversification of aminoacyl-tRNA synthetase activities genomic duplication.

Krahn N, Soll D, Vargas-Rodriguez O Front Physiol. 2022; 13:983245.

PMID: 36060688 PMC: 9437257. DOI: 10.3389/fphys.2022.983245.

References

Bertani G . Studies on lysogenesis. I. The mode of phage liberation by lysogenic Escherichia coli. J Bacteriol. 1951; 62(3):293-300. PMC: 386127. DOI: 10.1128/jb.62.3.293-300.1951. View

Parry R, Li W, COOPER H . Cloning, analysis, and overexpression of the gene encoding isobutylamine N-hydroxylase from the valanimycin producer, Streptomyces viridifaciens. J Bacteriol. 1997; 179(2):409-16. PMC: 178710. DOI: 10.1128/jb.179.2.409-416.1997. View

Garg R, Gonzalez J, Parry R . Biochemical characterization of VlmL, a Seryl-tRNA synthetase encoded by the valanimycin biosynthetic gene cluster. J Biol Chem. 2006; 281(37):26785-91. DOI: 10.1074/jbc.M603675200. View

Parry R, Li W . An NADPH:FAD oxidoreductase from the valanimycin producer, Streptomyces viridifaciens. Cloning, analysis, and overexpression. J Biol Chem. 1997; 272(37):23303-11. DOI: 10.1074/jbc.272.37.23303. View

Hegde S, Blanchard J . Kinetic and mechanistic characterization of recombinant Lactobacillus viridescens FemX (UDP-N-acetylmuramoyl pentapeptide-lysine N6-alanyltransferase). J Biol Chem. 2003; 278(25):22861-7. DOI: 10.1074/jbc.M301565200. View

Staubitz P, Neumann H, Schneider T, Wiedemann I, Peschel A . MprF-mediated biosynthesis of lysylphosphatidylglycerol, an important determinant in staphylococcal defensin resistance. FEMS Microbiol Lett. 2004; 231(1):67-71. DOI: 10.1016/S0378-1097(03)00921-2. View

Olsen R, Ramasamy K, Bhat K, Low C, Waring M . Synthesis and DNA-binding studies of [lac2,lac6]TANDEM, an analog of des-N-tetramethyltriostin A (TANDEM) having L-lactic acid substituted for each L-alanine residue. J Am Chem Soc. 2011; 108(19):6032-6. DOI: 10.1021/ja00279a060. View

Ma Y, Patel J, Parry R . A novel valanimycin-resistance determinant (vlmF) from Streptomyces viridifaciens MG456-hF10. Microbiology (Reading). 2000; 146 ( Pt 2):345-352. DOI: 10.1099/00221287-146-2-345. View

Imamura N, Kuga H, Otoguro K, Tanaka H, Omura S . Structures of jietacines: unique alpha,beta-unsaturated azoxy antibiotics. J Antibiot (Tokyo). 1989; 42(1):156-8. DOI: 10.7164/antibiotics.42.156. View

10.

Tao T, Alemany L, Parry R . Valanimycin biosynthesis: investigations of the mechanism of isobutylhydroxylamine incorporation. Org Lett. 2003; 5(8):1213-5. DOI: 10.1021/ol0340989. View

11.

Garg R, Ma Y, Hoyt J, Parry R . Molecular characterization and analysis of the biosynthetic gene cluster for the azoxy antibiotic valanimycin. Mol Microbiol. 2002; 46(2):505-17. DOI: 10.1046/j.1365-2958.2002.03169.x. View

12.

Maillard A, Biarrotte-Sorin S, Villet R, Mesnage S, Bouhss A, Sougakoff W . Structure-based site-directed mutagenesis of the UDP-MurNAc-pentapeptide-binding cavity of the FemX alanyl transferase from Weissella viridescens. J Bacteriol. 2005; 187(11):3833-8. PMC: 1112068. DOI: 10.1128/JB.187.11.3833-3838.2005. View

13.

Fujiu M, Sawairi S, Shimada H, Takaya H, Aoki Y, Okuda T . Azoxybacilin, a novel antifungal agent produced by Bacillus cereus NR2991. Production, isolation and structure elucidation. J Antibiot (Tokyo). 1994; 47(7):833-5. DOI: 10.7164/antibiotics.47.833. View

14.

Yamato M, Iinuma H, Naganawa H, Yamagishi Y, Hamada M, Masuda T . Isolation and properties of valanimycin, a new azoxy antibiotic. J Antibiot (Tokyo). 1986; 39(2):184-91. DOI: 10.7164/antibiotics.39.184. View

15.

Parry R, Li W . Purification and characterization of isobutylamine N-hydroxylase from the valanimycin producer Streptomyces viridifaciens MG456-hF10. Arch Biochem Biophys. 1997; 339(1):47-54. DOI: 10.1006/abbi.1996.9857. View

16.

Oku Y, Kurokawa K, Ichihashi N, Sekimizu K . Characterization of the Staphylococcus aureus mprF gene, involved in lysinylation of phosphatidylglycerol. Microbiology (Reading). 2004; 150(Pt 1):45-51. DOI: 10.1099/mic.0.26706-0. View

17.

Takahashi Y, Nakayama M, Watanabe I, Deushi T, Ishiwata H, Shiratsuchi M . Novel antifungal antibiotics maniwamycins A and B. II. Structure determination. J Antibiot (Tokyo). 1989; 42(11):1541-6. DOI: 10.7164/antibiotics.42.1541. View